Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States

Cancer

Volumn 123, Issue 6, 2017, Pages 1044-1050

  Beavis, Anna L ^a   Gravitt, Patti E ^b   Rositch, Anne F ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

and End Results (SEER); Behavioral Risk Factor Surveillance System; cervical cancer; disparities; Epidemiology; hysterectomy; mortality; Surveillance

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLACK PERSON; CANCER MORTALITY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; HEALTH DISPARITY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; POPULATION RISK; PREVALENCE; PUBLIC HEALTH; RACE DIFFERENCE; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER; AGE; CANCER REGISTRY; ETHNIC GROUP; HEALTH SURVEY; MIDDLE AGED; MORTALITY; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; MORTALITY; PUBLIC HEALTH SURVEILLANCE; SEER PROGRAM; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 85010824712     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30507     Document Type: Article

References (36)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2015;66:7–30.
2. Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer. 2014;120:2032–2038.
3. Merrill RM. Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States. Ann Epidemiol. 2006;16:880–887.
4. McDougall JA, Madeleine MM, Daling JR, Li CI. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 2007;18:1175–1186.
5. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109:1998–2002.
6. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; 2013.
7. Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM, Chuba PJ, Schwartz K. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol. 2005;97:550–558.
8. Stang A, Hawk H, Knowlton R, Gershman ST, Kuss O. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Ann Epidemiol. 2014;24:849–854.
9. Tabatabai MA, Kengwoung-Keumo JJ, Eby WM, et al. Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model. PLoS One. 2014;9:e107242.
10. Centers for Disease Control and Prevention. About the Behavioral Risk Factor Surveillance System (BRFSS). http://www.cdc.gov/brfss/about/about_brfss.htm. Accessed April 2, 2016.
11. Surveillance Epidemiology and End Results Program. SEER*Stat Database: Mortality—All COD, Aggregated with State, Total U.S. (1969-2013 ). Bethesda, MD: National Cancer Institute; 2016.
12. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes. 2001;20:1–10.
13. National Center for Health Statistics. Mortality data file with all county identifiers (2000-2012), as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program.
14. Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 1998;47:1–16.
15. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer Registration: Principles and Methods. Lyon, France: International Agency for Research on Cancer; 1991:126.
16. Joinpoint Regression Program, Version 4.2.0. Bethesda, MD: National Cancer Institute; 2015.
17. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–351.
18. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
19. Temkin SM, Minasian L, Noone AM. The end of the hysterectomy epidemic and endometrial cancer incidence: what are the unintended consequences of declining hysterectomy rates? Front Oncol. 2016;6:1–6.
20. Harlan LC, Bernstein AB, Kessler LG. Cervical cancer screening: who is not screened and why? Am J Public Health. 1991;81:885–890.
21. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528–1540.
22. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol. 2005;105:1323–1328.
23. Banister CE, Messersmith AR, Cai B, et al. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis. 2015;211:100–108.
24. Vidal AC, Smith JS, Valea F, et al. HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. Cancer Causes Control. 2014;25:1055–1062.
25. Wang SS, Sherman ME, Hildesheim A, Lacey JV, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100:1035–1044.
26. Galic V, Herzog TJ, Lewin SN, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125:287–291.
27. McCarthy AM, Dumanovsky T, Visvanathan K, Kahn AR, Schymura MJ. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control. 2010;21:1645–1655.
28. Movva S, Noone AM, Banerjee M, et al. Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer. 2008;112:1264–1271.
29. Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR. Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995-2001. J Womens Health (Larchmt). 2006;15:941–951.
30. Fleming S, Schluterman NH, Tracy JK, Temkin SM. Black and white women in Maryland receive different treatment for cervical cancer. PLoS One. 2014;9:e104344.
31. Sharma C, Deutsch I, Horowitz DP, et al. Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer. 2012;118:3618–3626.
32. Gentry-Maharaj A, Taylor H, Kalsi J, et al. Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMJ Open. 2014;4:e004421.
33. Phipps AI, Buist DSM. Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause. 2009;16:576–581.
34. Sills ES, Saini J, Steiner CA, McGee M, Gretz HF. Abdominal hysterectomy practice patterns in the United States. Int J Gynecol Obstet. 1998;63:277–283.
35. Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14:CR24–CR31.
36. Pierannunzi C, Town M, Garvin W, Shaw FE, Balluz L. Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep. 2012;61:410–413.